NNNN - CIK 0001982708
Anbio Biotechnology (NNNN) reported net income of $6.40M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $6.40M | +169.9% |
| FY 2024 | $2.37M | +5.3% |
| FY 2023 | $2.25M | -77.5% |
| FY 2022 | $10.01M | - |
Anbio Biotechnology (NNNN) reported net income of $6.40M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.